ADPT
Price
$7.90
Change
+$0.01 (+0.13%)
Updated
Apr 25, 02:14 PM (EDT)
Capitalization
1.17B
6 days until earnings call
PHAR
Price
$8.61
Change
+$0.03 (+0.35%)
Updated
Apr 25, 11:35 AM (EDT)
Capitalization
580.67M
13 days until earnings call
Ad is loading...

ADPT vs PHAR

Header iconADPT vs PHAR Comparison
Open Charts ADPT vs PHARBanner chart's image
Adaptive Biotechnologies
Price$7.90
Change+$0.01 (+0.13%)
Volume$105
Capitalization1.17B
Pharming Group
Price$8.61
Change+$0.03 (+0.35%)
Volume$116
Capitalization580.67M
ADPT vs PHAR Comparison Chart
Loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADPT vs. PHAR commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADPT is a Buy and PHAR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ADPT: $7.89 vs. PHAR: $8.58)
Brand notoriety: ADPT: Notable vs. PHAR: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADPT: 109% vs. PHAR: 26%
Market capitalization -- ADPT: $1.17B vs. PHAR: $580.67M
ADPT [@Biotechnology] is valued at $1.17B. PHAR’s [@Biotechnology] market capitalization is $580.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADPT’s FA Score shows that 0 FA rating(s) are green whilePHAR’s FA Score has 1 green FA rating(s).

  • ADPT’s FA Score: 0 green, 5 red.
  • PHAR’s FA Score: 1 green, 4 red.
According to our system of comparison, ADPT is a better buy in the long-term than PHAR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADPT’s TA Score shows that 4 TA indicator(s) are bullish.

  • ADPT’s TA Score: 4 bullish, 5 bearish.

Price Growth

ADPT (@Biotechnology) experienced а +7.64% price change this week, while PHAR (@Biotechnology) price change was +6.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.17%. For the same industry, the average monthly price growth was -4.24%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

ADPT is expected to report earnings on Jul 30, 2025.

PHAR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADPT($1.17B) has a higher market cap than PHAR($581M). ADPT YTD gains are higher at: 31.610 vs. PHAR (-14.754). PHAR has higher annual earnings (EBITDA): 7.56M vs. ADPT (-128.76M). ADPT has more cash in the bank: 222M vs. PHAR (172M). ADPT has less debt than PHAR: ADPT (89.4M) vs PHAR (127M). PHAR has higher revenues than ADPT: PHAR (286M) vs ADPT (179M).
ADPTPHARADPT / PHAR
Capitalization1.17B581M202%
EBITDA-128.76M7.56M-1,704%
Gain YTD31.610-14.754-214%
P/E RatioN/AN/A-
Revenue179M286M63%
Total Cash222M172M129%
Total Debt89.4M127M70%
FUNDAMENTALS RATINGS
ADPT: Fundamental Ratings
ADPT
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADPT
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Ad is loading...
ADPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYBKX82.76N/A
N/A
Rydex Banking A
SSTFX9.73N/A
N/A
Virtus KAR Capital Growth C
NRMGX15.62N/A
N/A
Neuberger Berman Mid Cap Growth R6
ALSAX8.32N/A
N/A
Alger Small Cap Growth A
MFRKX52.28N/A
N/A
MFS Research R6

ADPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADPT has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADPT jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADPT
1D Price
Change %
ADPT100%
+6.91%
AXON - ADPT
56%
Loosely correlated
+2.39%
VCYT - ADPT
54%
Loosely correlated
+2.15%
BEAM - ADPT
51%
Loosely correlated
+1.51%
ARRY - ADPT
50%
Loosely correlated
+5.31%
ABCL - ADPT
50%
Loosely correlated
+2.77%
More

PHAR and

Correlation & Price change

A.I.dvisor tells us that PHAR and APLM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PHAR and APLM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAR
1D Price
Change %
PHAR100%
+3.75%
APLM - PHAR
31%
Poorly correlated
+0.40%
ADPT - PHAR
27%
Poorly correlated
+6.91%
IBRX - PHAR
27%
Poorly correlated
N/A
ATXS - PHAR
26%
Poorly correlated
+0.19%
SONN - PHAR
25%
Poorly correlated
-4.23%
More